Brief: Theravance Biopharma Reports Q4 And Full Year 2021 Results

Theravance Biopharma

23/02/2022 22:44

Feb 23 (Reuters) - Theravance Biopharma Inc  TBPH.O :
    * THERAVANCE BIOPHARMA, INC. REPORTS FOURTH QUARTER AND FULL
YEAR
2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * TRELEGY Q4 2021 GLOBAL NET SALES: $479M, UP 52% FROM Q4
2020
    * QTRLY NET LOSS PER SHARE:BASIC AND DILUTED $0.43
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED
$173.5
MILLION AS OF DECEMBER 31, 2021
    * Q4 EARNINGS PER SHARE VIEW $-0.33 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn8Z00Hja 
Further company coverage:  TBPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))